Anthony Ladner

FDA investigator

Appears on 10 documents from 2016 to 2022, mostly at sites in Minnesota. Most often cites control of microbiological contamination (21 CFR 211.113).

10
Documents on file
4.2
Observations per 483
2016
First seen
2022
Most recent

What they cite most

From 38 observations

Activity by year

2016: 2, 2017: 2, 2018: 3, 2019: 1, 2021: 1, 2022: 1

Where

Minnesota 8 · Illinois 1 · Kansas 1

Is Anthony Ladner coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 Fa g r on Compound ing Service sMar 24, 2022 · Wichita, Kansas
483 IntegraDose Compounding Services LLCAug 2, 2021 · Minneapolis, Minnesota
483 Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs PharmacySep 27, 2019 · Roselle, Illinois
483 Thrifty White Drug #762Sep 21, 2018 · Minne a polis, Minnesota
Response Fairview Pharmacy Services, LLCMay 8, 2018 · Minneapolis, Minnesota
483 Fairview Compounding PharmacyApr 18, 2018 · Minneapolis, Minnesota
483 Heartland I.V. CareJul 14, 2017 · Saint Paul, Minnesota

About this profile

What does Anthony Ladner inspect?

Anthony Ladner appears on 10 documents on file covering 9 sites, mostly in Minnesota.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.42 and FDCA 501(a)(2)(A).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Anthony Ladner is dated Mar 24, 2022.